Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence C Kuo

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
Novel HIV-1 protease inhibitors active against multiple PI-resistant viral strains: coadministration with indinavirNancy J Kevin, Joseph L Duffy, Brian A Kirk, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2008
Structure-based design of novel groups for use in the P1 position of thrombin inhibitor scaffolds. Part 2: N-acetamidoimidazolesRichard C A Isaacs, Mark G Solinsky, Kellie J Cutrona, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2005
Development of an oxazolopyridine series of dual thrombin/factor Xa inhibitors via structure-guided lead optimizationJames Z Deng, Daniel R McMasters, Philippe M A Rabbat, et al.
The Journal of Biological Chemistry|January 30, 2003
Inhibition of hepatitis C virus RNA replication by 2'-modified nucleoside analogsSteven S Carroll, Joanne E Tomassini, Michele Bosserman, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2003
Unexpected enhancement of thrombin inhibitor potency with o-aminoalkylbenzylamides in the P1 positionKenneth E Rittle, James C Barrow, Kellie J Cutrona, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2002
A combinatorial library of indinavir analogues and its in vitro and in vivo studiesYuan Cheng, Thomas A Rano, Tracy T Huening, et al.
Bioorganic & Medicinal Chemistry Letters|September 4, 2007
Kinesin spindle protein (KSP) inhibitors. Part 8: Design and synthesis of 1,4-diaryl-4,5-dihydropyrazoles as potent inhibitors of the mitotic kinesin KSPAnthony J Roecker, Paul J Coleman, Swati P Mercer, et al.
Protein Science : a Publication of the Protein Society|February 11, 2011
Crystal structure of a soluble form of human monoglyceride lipase in complex with an inhibitor at 1.35 Å resolutionCéline Schalk-Hihi, Carsten Schubert, Richard Alexander, et al.
The Journal of Biological Chemistry|September 2, 2017
Discovery of a highly selective chemical inhibitor of matrix metalloproteinase-9 (MMP-9) that allosterically inhibits zymogen activationRobert H Scannevin, Richard Alexander, Tara Mezzasalma Haarlander, et al.
Bioorganic & Medicinal Chemistry Letters|April 11, 2006
Kinesin spindle protein (KSP) inhibitors. Part 4: Structure-based design of 5-alkylamino-3,5-diaryl-4,5-dihydropyrazoles as potent, water-soluble inhibitors of the mitotic kinesin KSPChristopher D Cox, Maricel Torrent, Michael J Breslin, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
Novel HIV-1 protease inhibitors active against multiple PI-resistant viral strains: coadministration with indinavirNancy J Kevin, Joseph L Duffy, Brian A Kirk, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2008
Structure-based design of novel groups for use in the P1 position of thrombin inhibitor scaffolds. Part 2: N-acetamidoimidazolesRichard C A Isaacs, Mark G Solinsky, Kellie J Cutrona, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2005
Development of an oxazolopyridine series of dual thrombin/factor Xa inhibitors via structure-guided lead optimizationJames Z Deng, Daniel R McMasters, Philippe M A Rabbat, et al.
The Journal of Biological Chemistry|January 30, 2003
Inhibition of hepatitis C virus RNA replication by 2'-modified nucleoside analogsSteven S Carroll, Joanne E Tomassini, Michele Bosserman, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2003
Unexpected enhancement of thrombin inhibitor potency with o-aminoalkylbenzylamides in the P1 positionKenneth E Rittle, James C Barrow, Kellie J Cutrona, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2002
A combinatorial library of indinavir analogues and its in vitro and in vivo studiesYuan Cheng, Thomas A Rano, Tracy T Huening, et al.
Bioorganic & Medicinal Chemistry Letters|September 4, 2007
Kinesin spindle protein (KSP) inhibitors. Part 8: Design and synthesis of 1,4-diaryl-4,5-dihydropyrazoles as potent inhibitors of the mitotic kinesin KSPAnthony J Roecker, Paul J Coleman, Swati P Mercer, et al.
Protein Science : a Publication of the Protein Society|February 11, 2011
Crystal structure of a soluble form of human monoglyceride lipase in complex with an inhibitor at 1.35 Å resolutionCéline Schalk-Hihi, Carsten Schubert, Richard Alexander, et al.
The Journal of Biological Chemistry|September 2, 2017
Discovery of a highly selective chemical inhibitor of matrix metalloproteinase-9 (MMP-9) that allosterically inhibits zymogen activationRobert H Scannevin, Richard Alexander, Tara Mezzasalma Haarlander, et al.
Bioorganic & Medicinal Chemistry Letters|April 11, 2006
Kinesin spindle protein (KSP) inhibitors. Part 4: Structure-based design of 5-alkylamino-3,5-diaryl-4,5-dihydropyrazoles as potent, water-soluble inhibitors of the mitotic kinesin KSPChristopher D Cox, Maricel Torrent, Michael J Breslin, et al.
Pageof 4